4//SEC Filing
Ferraresso Michael 4
Accession 0001628280-22-003057
CIK 0001325879other
Filed
Feb 16, 7:00 PM ET
Accepted
Feb 17, 5:01 PM ET
Size
5.4 KB
Accession
0001628280-22-003057
Insider Transaction Report
Form 4
Ferraresso Michael
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2022-02-15+220,000→ 220,000 totalExercise: $3.67Exp: 2032-02-15→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in equal monthly installments from February 15, 2022 through February 15, 2026, subject to the Reporting Person's continued service to the Company.
Documents
Issuer
AVEO PHARMACEUTICALS, INC.
CIK 0001325879
Entity typeother
Related Parties
1- filerCIK 0001853186
Filing Metadata
- Form type
- 4
- Filed
- Feb 16, 7:00 PM ET
- Accepted
- Feb 17, 5:01 PM ET
- Size
- 5.4 KB